# Anteris Technologies

> Australian biotechnology company

**Wikidata**: [Q117355390](https://www.wikidata.org/wiki/Q117355390)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Anteris_Technologies)  
**Source**: https://4ort.xyz/entity/anteris-technologies

## Summary
Anteris Technologies is an Australian biotechnology company that is a public company, meaning it offers its securities for sale to the general public, typically through a stock exchange. This classification allows the company to raise capital from a wide pool of investors and is distinct from private companies that do not publicly trade their shares.

## Key Facts
- Anteris Technologies is a public company, offering its securities for sale to the general public.
- It is a type of joint-stock company and a specific legal form of organization.
- The company is known by aliases such as Anteris and is listed on Wikipedia in English.
- It is classified as a business, enterprise, and public company.
- The entity has a sitelink count of 1 on Wikipedia, indicating its presence in the knowledge base.

## FAQs
**What is Anteris Technologies?**
Anteris Technologies is an Australian biotechnology company that operates as a public company, offering its securities for sale to the general public through a stock exchange.

**How is Anteris Technologies different from a private company?**
Unlike a private company, Anteris Technologies allows its shares to be traded on a public market, enabling any member of the general public to become an owner.

**What are the aliases for Anteris Technologies?**
The company is also known by the alias "Anteris" and is listed under the Wikipedia title "Anteris Technologies."

## Why It Matters
Anteris Technologies plays a critical role in the biotechnology sector by enabling large-scale capital formation for research, development, and innovation. As a public company, it provides liquidity for investors, allowing them to easily buy and sell ownership stakes. This structure promotes transparency and accountability, which are essential for maintaining investor confidence in the global economy.

## Notable For
- Being a publicly traded biotechnology company in Australia, facilitating investment and economic growth.
- Adhering to strict regulatory disclosure and reporting standards, ensuring transparency for investors.
- Providing a mechanism for wealth creation and retirement savings through public stock markets.

## Body

### Definition and Core Characteristics
Anteris Technologies is defined by its status as a public company, which means it offers its securities, such as stocks and bonds, for sale to the general public. This is in contrast to private companies, which raise funds from a smaller, closed group of investors. The company's ability to raise capital through public offerings allows it to support large-scale biotechnology projects and innovations.

### Terminology and Aliases
The entity is known by several names, including "Anteris" and "Anteris Technologies." These aliases are used across different contexts to refer to the same company. The term "public company" is synonymous with "publicly traded company," "publicly held company," and "listed company," all of which describe the company's status as a publicly traded entity.

### Classification and Type
Anteris Technologies is classified as a business, enterprise, and public company. It is a specific type of joint-stock company and is considered a distinct legal form of organization. This classification is important for understanding its governance, ownership, and regulatory requirements.

### Ownership and Governance
The ownership of Anteris Technologies is held by its shareholders, who can be individuals, institutional investors, or other entities that have purchased its publicly traded securities. Governance is typically provided by a board of directors elected by the shareholders, ensuring a separation of ownership and control.

### Global Presence and Recognition
The concept of a public company, including Anteris Technologies, is recognized globally. The company's presence in Wikipedia in English indicates its recognition as a notable entity in the biotechnology sector. It is a subject covered in financial resources and academic literature, highlighting its importance in the global economy.